Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. - Wikidata - awgldk - TriplyDB

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

http://www.wikidata.org/entity/Q46575197

about

Entecavir for chronic hepatitis B Entecavir for chronic hepatitis B Antiviral drugs for viruses other than human immunodeficiency virus Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant KASL clinical practice guidelines: management of chronic hepatitis B Management of chronic hepatitis B infection: current treatment guidelines, challenges, and new developments Viral hepatitis B and C in children A Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen Secretion Mechanistic characterization and molecular modeling of hepatitis B virus polymerase resistance to entecavir Recent advances in micro/nanotechnologies for global control of hepatitis B infection Advancing patient care: integrating new data.Management of chronic hepatitis B virus infection: current perspectives for the nurse practitioner.Chronic hepatitis B: whom to treat and for how long? Propositions, challenges, and future directions.Antiviral therapy and resistance with hepatitis B virus infection.Clinical impact of the early alanine amininotransferase flare during tenofovir monotherapy in treatment-naïve patients with chronic hepatitis B.Virologic response at 12 months of treatment predicts sustained antiviral efficacy in patients with adefovir-treated Lamivudine-resistant chronic hepatitis B Peginterferon alpha-based therapy for chronic hepatitis B focusing on HBsAg clearance or seroconversion: a meta-analysis of controlled clinical trials.Liver cirrhosis Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.Practical approach in hepatitis B e antigen-negative individuals to identify treatment candidates.Antiviral treatment of chronic hepatitis B virus (HBV) infections Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B Review of hepatitis B therapeutics.Current status of antiviral therapy for hepatitis B Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.AASLD guidelines for treatment of chronic hepatitis B.Effects of nucleoside analogue on patients with chronic hepatitis B-associated liver failure: meta-analysis Entecavir: a new nucleoside analog for the treatment of chronic hepatitis B infection.The role of entecavir in the treatment of chronic hepatitis B.Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.A one-year trial of entecavir treatment in patients with HBeAg-positive chronic hepatitis B.Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2).Clinical update: hepatitis B Safety and efficacy of entecavir for the treatment of chronic hepatitis B.Emerging drugs for hepatitis B.Intrahepatic HBV DNA as a predictor of antivirus treatment efficacy in HBeAg-positive chronic hepatitis B patients.Management and treatment of hepatitis B virus in patients with HIV infection: A practical guide for health care professionals.Recent advances in the management of chronic hepatitis B.Pegylated interferon alfa for chronic hepatitis B: systematic review and meta-analysis.Delayed Reduction of Hepatitis B Viral Load and Dynamics of Adefovir-Resistant Variants during Adefovir plus Entecavir Combination Rescue Therapy

P2860

Q24195119-5C8AF495-0CC4-4584-8CFA-BF80FA9AC7E3 Q24244842-0AFF66AD-9FA4-4D0C-8C10-B883A261A1F6 Q24635330-15A20334-2899-49F6-93E5-081A5549D075 Q25256648-8573DE66-0B35-4CC5-A12B-75D0B30CD10C Q26752475-0002D4BB-353E-42DF-B10B-74934AF2CEB7 Q27008984-EFBF3847-C108-49B7-9C09-A678E6613195 Q27473273-378D5DD8-3F8B-4051-B423-D6675861D6C4 Q27484471-7AB32B66-70AC-4536-80C7-54705788AE47 Q28748931-5DD73E6A-D424-4217-9B1A-FB115E695B81 Q30394611-C7C63AC2-43B3-4033-9AB5-03DE3F76BF59 Q31031231-42323EE1-68FB-4115-A05A-EFBB1BD91658 Q33242705-85318BE3-48FC-4136-8E07-56C9AEFD6239 Q33718958-0C5A76F2-8776-482F-87FB-512A6F2FDBF3 Q33787531-5943929F-80F8-4654-A8D5-3F692FD89244 Q33872988-43AEAC43-E558-4744-903E-C5EDE3E62859 Q33918275-09C05D52-0576-4D9B-807A-8E6E82D20041 Q33926126-7B229D3D-076F-4CD1-8A80-3CF14EAD4310 Q34010340-0EE8D1E3-6275-4353-9397-1B0777111619 Q34017787-2FA5640D-3140-4264-9DD2-A325A8CFB605 Q34168465-1BDDD8E9-A814-4424-A1CB-B4C9F53920EE Q34223779-E27FDA03-6DF4-416C-AD1A-77AA1A07A3F5 Q34225464-6CB27F74-1E72-4006-8AE6-ED5C9CD6C358 Q34296410-6DD834E0-F1C6-4884-8F4D-8B8904F2F775 Q34408879-A73A4107-1557-48C7-9A24-CA9170E1F279 Q34489239-7C47C3CC-CF79-49D7-A27F-83CE24D74735 Q34501660-6526AFCC-7C07-4253-B16E-F5A1C46054CF Q34575663-96F6B785-2B19-4186-84C1-96FCEE8066C1 Q34584406-888548A5-5E68-4742-B6ED-D9F29B4EE1E8 Q34592640-AD95D827-320C-4754-A942-4C454F2C359E Q34594403-2E2D6D6E-2D92-4FB7-91D1-8D4F05438F46 Q34604857-8DF643EE-0197-4A13-B737-A4AFFC01BD34 Q34719476-D7FE0251-9A8C-456F-9AF4-FD793D43E8A2 Q34996687-13246C7E-09E7-428D-9974-0FD34DA5A365 Q35026611-C8CEDF2B-AD9A-4277-B0E1-29A9742E6361 Q35359369-83259A3C-BAA1-4C2E-BB97-1500FD58E2C2 Q35397329-C1DCAA30-72A0-4771-B8C0-1935BAD60912 Q35433965-A7C03736-41CF-499A-9B00-AD57D7772627 Q35582461-3F38333B-3B23-4203-A429-60A339776A6C Q35628610-A534B845-21A0-4A23-944B-BE50F8A1F528 Q35635522-6B478C63-3FFC-4866-A6C9-EAF9A8097168

P2860

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

http://www.wikidata.org/entity/Q46575197

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@en

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@nl

type

label

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@en

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@nl

prefLabel

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@en

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@nl

P1433

Q46575197-37F35E68-2CB8-48B2-8D99-1ADDFA473C51

P1476

Q46575197-18DC5041-2555-432D-AF0F-5DF3F1584ABA

P2093

Q46575197-0A90D8E9-A0B5-4AB1-857D-D8092CDA5741

Q46575197-0C1EA972-4E0D-445F-95C6-22772CB7AE9E

Q46575197-11119EB8-E68C-4B2C-AB17-286B7A0547EE

Q46575197-41D84FBF-FA86-4019-8EEE-17C65F2B92EF

Q46575197-70810A31-6AA7-42F9-AE55-CBCDC2F67A71

Q46575197-95E6F883-633C-4C4F-B4B6-7B3F2EFE69A5

Q46575197-9D5A46E1-4687-4A45-B100-8324C000D2DA

Q46575197-A2DF6530-DE5A-44D6-8ACF-BC2C937D15CC

Q46575197-AA4F4BDD-B2D7-4DAF-B477-6031D301338A

Q46575197-B39F1E5D-2D97-4ADA-98B7-A0513B3EE731

P304

Q46575197-0C44DEA9-8475-4DD2-A676-6C8FDC9D0F85

P31

Q46575197-CD44E92B-236A-4315-8E18-DE5F9FAB2AAE

P356

Q46575197-9E5D3978-5DB3-4AC2-BF18-E9B058E19D2F

P407

Q46575197-B9E65C07-9A55-4822-B126-AB917FAA1634

P433

Q46575197-86845D61-48D9-478F-98DD-6DEB2C30EBB3

P478

Q46575197-C661D0D6-C3B1-4A55-A46B-6F3897056CAC

P577

Q46575197-98E76B22-287A-4A82-B905-8F7CDCDA5AA9

P5875

Q46575197-213FA1AE-A881-466F-BE97-85D611C897CF

P698

Q46575197-56DE3A43-EE69-497D-AA14-213D2BA2569A

P356

P1433

The New England Journal of Medicine

P1476

Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B.

@en

P2093

Adefovir Dipivoxil 438 Study Group

http://www.w3.org/2001/XMLSchema#string

Carol L Brosgart

http://www.w3.org/2001/XMLSchema#string

E Jenny Heathcote

http://www.w3.org/2001/XMLSchema#string

George Kitis

http://www.w3.org/2001/XMLSchema#string

Graeme Currie

http://www.w3.org/2001/XMLSchema#string

Jia Ma

http://www.w3.org/2001/XMLSchema#string

Mario Rizzetto

http://www.w3.org/2001/XMLSchema#string

Nicolaos C Tassopoulos

http://www.w3.org/2001/XMLSchema#string

Patrick Marcellin

http://www.w3.org/2001/XMLSchema#string

Sarah Arterburn

http://www.w3.org/2001/XMLSchema#string

P304

2673-2681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA042957

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

352

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7755933

http://www.w3.org/2001/XMLSchema#string

P698

15987916

http://www.w3.org/2001/XMLSchema#string